Jiuzhou Pharmaceutical cancels repurchased shares, reducing capital
Zhejiang Jiuzhou Pharmaceutical (SSE:603456) has completed the cancellation of 5,789,800 repurchased shares, initially intended for equity incentives but redirected to reduce the company's registered capital. The decision, approved by shareholders in April and May 2025, reflects the board's confidence in the company's long-term value. The cancellation reduces the total share capital from 895,235,828 to 889,446,028 shares and does not affect the proportion of shares subject to selling restrictions, according to the company's announcement on June 26, 2025. The repurchased shares were acquired at a cost of CNY 99,893,380.10.
This report was generated by FilingReader's AI system from regulatory filings and company disclosures. To request a correction, contact editorial@filingreader.com
News Alerts
Get instant email alerts when Zhejiang Jiuzhou Pharmaceutical publishes news
Free account required • Unsubscribe anytime